Torben Møller-Pedersen

Torben Møller-Pedersen

Auto-generated profile, based on publicly available information

Torben Møller-Pedersen

Department of Ophthalmology, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2000 in Ophthalmology
Verified
Journal Article
Closed access
TMTorben Møller-Pedersen
Torben Møller-Pedersen
HCH.DWight Cavanagh
H.DWight Cavanagh
W. Matthew PetrollW. Matthew Petroll
W. Matthew Petroll
JJJames Jester
James Jester

1 March 2004 in Experimental Eye Research
Verified
Journal Article
Closed access
TMTorben Møller-Pedersen
Torben Møller-Pedersen

1 March 1998
Verified
Journal Article
Closed access
TMT Møller-Pedersen
T Møller-Pedersen
HLH F Li
H F Li
WPW M Petroll
W M Petroll
HCH D Cavanagh
H D Cavanagh
JJJames Jester
James Jester

1 September 2001 in British Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
TMT Moller-Pedersen
T Moller-Pedersen
UHU Hartmann
U Hartmann
HMHolger Jon Møller
Holger Jon Møller
NEN Ehlers
N Ehlers
KEK Engelmann
K Engelmann
AIM To evaluate the ability of different commercially available cell culture solutions to preserve human donor corneas during 3 weeks of “closed system” organ culture at physiological temperature. This screening was performed in an attempt to establish a rational basis for the development of a serum-free organ culture medium for eye banking. METHODS 72 normal human donor corneas were organ cultured for 21 days at 31°C in eight different test media (nine corneas in each group). The basic culture solutions included: minimal essential medium (MEM), MEM with stabilised l-glutamine, M199, DIF-1000, SFM, F99, and F99 with ascorbic acid, insulin, bFGF, transferrin, selenium, and lipids (termed F99-Sr). All media were supplemented with 2% fetal calf serum (FCS), except for MEM, which was also studied at 8% FCS. The evaluation parameters included: (1) the endothelial cell loss as evaluated using trypan blue staining; (2) the ability of keratocytes and endothelial cells to incorporate tritiated uridine into RNA as evaluated using autoradiography and digital image analysis; (3) the leakage of immunogenic keratan sulphate as assessed using ELISA; and (4) changes in storage medium pH, glucose, and lactate content. RESULTS SFM induced the lowest endothelial cell loss of 14% (SD 2%) and the highest RNA synthesis rates of all test solutions supplemented with 2% FCS. Corneas stored in SFM also showed the least leakage of keratan sulphate and the highest glucose consumption and lactate production. In five media (MEM with 2% FCS, MEM with stabilised l-glutamine, M199, F99, and F99-Sr), comparable and intermediate potentials for organ culture were observed with endothelial cell loss of 16–19%. By contrast, 29% (4%) of the endothelium was lost after storage in DIF-1000. Interestingly, the use of 8% FCS (in MEM) had a marked protective effect on the endothelium, which showed the highest RNA synthetic activity combined with a cell loss of only 11% (4%), compared with 19% (6%) at 2% FCS (p<0.05). CONCLUSION Among the present test solutions, SFM appears to be the most prominent candidate for a new corneal organ culture medium and should be further tested and possibly refined to effectively substitute serum addition.

25 September 2001 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
TMTorben Møller-Pedersen
Torben Møller-Pedersen
UHUlrike Hartmann
Ulrike Hartmann
NENiels Ehlers
Niels Ehlers
KEKatrin Engelmann
Katrin Engelmann